Nitzan Rosenfeld receives Translational Research Award
Congratulations to Nitzan Rosenfeld, who has won the 2013 British Association for Cancer Research Translational Research Award.
The purpose of the award is to recognise and reward the achievements of an individual whose work has made significant contributions to translational (laboratory – clinic) cancer research.
The lab are working on developing effective methods to make use of circulating tumour DNA (ctDNA), which is found in blood and other body fluids and contains much useful information about a patient’s cancer. For example, by using genomic techniques to study ctDNA researchers can learn about the evolution of a patient’s tumour and how it is developing resistance to therapy. The advantage of using ctDNA to diagnose and monitor disease is that it can be collected relatively non-invasively, through a blood test rather than a tumour biopsy, and ease of sample collection means that you can take many more samples to follow the development and changes in a tumour.
Related News
See all news-
Dr Richard Mair to co-lead £13.7M investment for brain tumour research
19th December 2025
The National Institute for Health and Care Research (NIHR) has today announced a £13.7 million investment that will support ground-breaking research to develop novel brain tumour treatments in the UK.
Find out more -
Order of cancer-driving mutations affects the chance of tumour development
3rd December 2025
New research from the Winton Group has revealed that the order of cancer-driving mutations plays an important role in whether tumours in the intestine can develop.
Find out more -
Cancer Detectives: New Channel 4 Documentary Showcases Cambridge Brain Cancer Trial
27th November 2025
A Cambridge researcher offering new hope to people with brain tumours is the focus of a documentary exploring the science behind the next big breakthroughs.
Find out more